S3496 A Rare Case of Biliary Cast Syndrome After Orthotopic Liver Transplantation

Introduction: Bile cast syndrome (BCS) is a rare but serious complication of orthotopic liver transplantation (OLT), seen in up to 4-18 % of recipients. Its pathophysiology is unclear but likely involves a blood supply-demand mismatch, such as a hepatic artery thrombosis or liver graft hilum narrowing. It typically presents as common bile duct obstruction with or without cholangitis. We present a case of BCS that occurred 9 weeks after receiving liver transplant. Case Description/Methods: A 48-year-old woman underwent an OLT for Alcohol-induced acute liver failure in the setting of decompensated cirrhosis (MELD >41). Post-transplant immunosuppression included Methylprednisolone, mycophenolate mofetil, and tacrolimus. Two weeks later, she presented with abdominal pain and leukocytosis (WBC 46K). Computed tomography abdomen showed a moderate volume of intraperitoneal fluid. A drain was placed, and cholangiogram revealed bile leakage from cystic duct remnant into perihepatic space. One week later, she was admitted with severe anemia (Hb 5.9 g/dl) for which she received multiple transfusions. Computed tomography Abdomen revealed a 25 cm perihepatic biloma. Four days later, she was readmitted with severe anemia (Hb 6 g/dl), and a low reticulocyte count raised concern for bone marrow suppression. Esophagogastroduodenoscopy revealed a non-bleeding gastric ulcer. She experienced cardiac arrest with successful resuscitation and was admitted to the intensive care unit. She developed septic shock with positive blood cultures for MRSE, VRE, and gram-negative bacteria. Endoscopic retrograde cholangiopancreatography (ERCP) was performed to address a possible bile leak and suspected ascending cholangitis. It revealed a proximally migrated, occluded biliary stent, which was removed. At 9 weeks post-transplant, she presented with jaundice and abdominal pain. Labs showed cholestasis (total bilirubin 4.8 mg/dL, ALP 948, GGT of 1254, AST 216, ALT 350). ERCP revealed filling defects in the left and right hepatic ducts and all intrahepatic branches, indicative of biliary casts. Lithotripsy failed, but spybite basket removed a large cast. A biliary stent was placed with good bile flow. Discussion: Biliary Cast Syndrome (BCS) post-transplant is associated with significant morbidity and mortality. Risk factors include ischemia, rejection, infection, and bile leaks. In this case, severe anemia, prolonged CPR, and biloma may have contributed to biliary ischemia and cast development. BCS typically presents within 3–12 months post-transplant; our patient presented at 9 weeks. Early recognition is essential for timely intervention and improved outcomes.

Authors

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001141444.95510.76
Primary Topic
Parathyroid Disorders and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S3496 A Rare Case of Biliary Cast Syndrome After Orthotopic Liver Transplantation

Ahmed Attia, Ameer Abutaleb, Abdelrhman Refaey, Ahmed Ebeid et al.
The American Journal of Gastroenterology
Parathyroid Disorders and Treatments
article

S3496 A Rare Case of Biliary Cast Syndrome After Orthotopic Liver Transplantation

Ahmed Attia, Ameer Abutaleb, Abdelrhman Refaey, Ahmed Ebeid, Mohamed Abdou, Stephen Gray
article en

Abstract

Introduction: Bile cast syndrome (BCS) is a rare but serious complication of orthotopic liver transplantation (OLT), seen in up to 4-18 % of recipients. Its pathophysiology is unclear but likely involves a blood supply-demand mismatch, such as a hepatic artery thrombosis or liver graft hilum narrowing. It typically presents as common bile duct obstruction with or without cholangitis. We present a case of BCS that occurred 9 weeks after receiving liver transplant. Case Description/Methods: A 48-year-old woman underwent an OLT for Alcohol-induced acute liver failure in the setting of decompensated cirrhosis (MELD >41). Post-transplant immunosuppression included Methylprednisolone, mycophenolate mofetil, and tacrolimus. Two weeks later, she presented with abdominal pain and leukocytosis (WBC 46K). Computed tomography abdomen showed a moderate volume of intraperitoneal fluid. A drain was placed, and cholangiogram revealed bile leakage from cystic duct remnant into perihepatic space. One week later, she was admitted with severe anemia (Hb 5.9 g/dl) for which she received multiple transfusions. Computed tomography Abdomen revealed a 25 cm perihepatic biloma. Four days later, she was readmitted with severe anemia (Hb 6 g/dl), and a low reticulocyte count raised concern for bone marrow suppression. Esophagogastroduodenoscopy revealed a non-bleeding gastric ulcer. She experienced cardiac arrest with successful resuscitation and was admitted to the intensive care unit. She developed septic shock with positive blood cultures for MRSE, VRE, and gram-negative bacteria. Endoscopic retrograde cholangiopancreatography (ERCP) was performed to address a possible bile leak and suspected ascending cholangitis. It revealed a proximally migrated, occluded biliary stent, which was removed. At 9 weeks post-transplant, she presented with jaundice and abdominal pain. Labs showed cholestasis (total bilirubin 4.8 mg/dL, ALP 948, GGT of 1254, AST 216, ALT 350). ERCP revealed filling defects in the left and right hepatic ducts and all intrahepatic branches, indicative of biliary casts. Lithotripsy failed, but spybite basket removed a large cast. A biliary stent was placed with good bile flow. Discussion: Biliary Cast Syndrome (BCS) post-transplant is associated with significant morbidity and mortality. Risk factors include ischemia, rejection, infection, and bile leaks. In this case, severe anemia, prolonged CPR, and biloma may have contributed to biliary ischemia and cast development. BCS typically presents within 3–12 months post-transplant; our patient presented at 9 weeks. Early recognition is essential for timely intervention and improved outcomes.

The American Journal of GastroenterologyVol. 120(10S2)
Openalex Percentile: Top 64%
Parathyroid Disorders and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.